News

In a series of 41 whole-body PET studies conducted in 34 females, this imaging technique appeared to be useful in the post-therapy surveillance of endometrial cancers, both for the accurate ...
Types & Formulations of Bioidentical Estrogens Compounded estrogen formulations for menopause contain estradiol, estrone and/or estriol. [5, 16, 17] Currently, products such as Biest (biestrogen ...
It all comes down to access “Every single day, I would have a hot flash, maybe two times a day. I was walking around with paper towels under my underarms.” […] ...
You look in the mirror and see a spot. It wasn’t there just yesterday, maybe. Sometimes we poke or try to squeeze it. But that bump can be something else entirely. Your body is often trying to tell ...
TOKYO & BASKING RIDGE, N.J., June 09, 2025--DESTINY-Endometrial01 Ph. 3 Trial of ENHERTU Initiated as 1L Therapy in Patients w/ HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer ...
GSK's drug was cleared by the FDA for use in relapsed endometrial cancer with dMMR mutations in 2021, while Keytruda got the go-ahead for relapsed cases with MSI-H or dMMR mutations last year.
In endometrial cancer, upwards of 70% of tumours are mismatch repair proficient (MMRp)/microsatellite stable (MSS), so the new approval unlocks the lion's share of the market for GSK.
Endometrial cancer is the second most common gynecologic cancer and the sixth most common cancer among women globally. In 2022, ~420,000 cases were diagnosed, which led to ~97,000 deaths worldwide.
HealthDay News — For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life, ...
Endometrial Cancer Stages After being diagnosed with endometrial cancer, doctors will try to figure out if it has spread and, if so, how far. This process is called staging. The stage of a cancer ...